Guardant Health, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the Annual Meeting of Stockholders held on June 12, 2024. The filing covers the voting outcomes for director elections, auditor ratification, and executive compensation advisory votes.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
- Director Elections (Proposal 1): All nominees were elected.
- Helmy Eltoukhy: 89,595,582 votes for; 1,407,958 withheld.
- Steve Krognes: 64,412,704 votes for; 25,590,836 withheld.
- AmirAli Talasaz: 90,503,626 votes for; 499,914 withheld.
- Auditor Ratification (Proposal 2): Ratification of Deloitte & Touche LLP was approved with 96,479,592 votes for and 676,160 votes against.
- Executive Compensation (Proposal 3): The advisory vote to approve named executive officer compensation was not approved.
- Votes For: 84,585,946
- Votes Against: 5,812,828
- Abstentions: 604,766
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, or specific risk factors beyond the voting results.
Key Facts for Investor Verification
- Verify the implications of the failed "Say-on-Pay" vote (Proposal 3) on future executive compensation structures.
- Review the significant number of votes withheld for director Steve Krognes (25.6 million) compared to other nominees.
- Confirm the total number of broker non-votes (6,193,090) which impacted the director election and compensation vote totals.